Neumora Therapeutics, Inc. Common Stock (NMRA) Ownership

$0.72

north_east
$0.01 (1.65%)
Day's range
$0.69
Day's range
$0.81

Neumora Therapeutics, Inc. Common Stock Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 02/13/2025 7.84 M $83.09 M   1.15% 4.92%
BLACKROCK, INC. 02/07/2025 7.11 M $75.33 M   14.87% 4.46%
SOFTBANK GROUP CORP. 02/14/2025 6.54 M $69.34 M   -13.33% 4.10%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 02/14/2025 5.00 M $53.03 M   -4.31% 3.14%
VANGUARD GROUP INC 02/11/2025 4.57 M $48.47 M   4.46% 2.87%
MIC CAPITAL MANAGEMENT UK LLP 02/14/2025 4.46 M $47.28 M   0.00% 2.80%
SIREN, L.L.C. 02/14/2025 4.40 M $46.60 M   68.65% 2.76%
DEEP TRACK CAPITAL, LP 02/14/2025 4.00 M $42.40 M   604.94% 2.51%
CAPITAL INTERNATIONAL INVESTORS 02/13/2025 3.70 M $39.22 M   692.06% 2.32%
WELLCOME TRUST LTD (THE) AS TRUSTEE OF THE WELLCOME TRUST 01/13/2025 3.31 M $35.08 M   0.00% 2.08%
ICONIQ CAPITAL, LLC 02/14/2025 2.56 M $27.13 M   -24.70% 1.61%
LUNATE HOLDING RSC LTD 02/14/2025 2.12 M $22.52 M   100.00% 1.33%
ECOR1 CAPITAL, LLC 02/14/2025 2.07 M $21.96 M   0.00% 1.30%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.97 M $20.89 M   -0.48% 1.24%
JOHNSON & JOHNSON 02/13/2025 1.85 M $19.60 M   0.00% 1.16%
CAPTION MANAGEMENT, LLC 02/14/2025 1.52 M $16.10 M   653.17% 0.95%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 1.50 M $15.90 M   100.00% 0.94%
DEEP TRACK CAPITAL, LP 02/14/2025 1.19 M $12.61 M   559.17% 0.75%
BAKER BROS. ADVISORS LP 02/14/2025 1.03 M $10.97 M   0.00% 0.65%
ROCK SPRINGS CAPITAL MANAGEMENT LP 02/14/2025 955,106 $10.12 M   15.34% 0.60%
IKARIAN CAPITAL, LLC 02/14/2025 900,000 $9.54 M   125.00% 0.56%
ORBIMED ADVISORS LLC 02/14/2025 804,996 $8.53 M   -46.33% 0.51%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 793,800 $8.41 M   7,606.80% 0.50%
NORTHERN TRUST CORP 02/14/2025 734,847 $7.79 M   7.69% 0.46%
MORGAN STANLEY 02/14/2025 731,412 $7.75 M   106.79% 0.46%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 704,154 $7.46 M   0.84% 0.44%
GOLDMAN SACHS GROUP INC 02/11/2025 640,923 $6.79 M   88.50% 0.40%
SIO CAPITAL MANAGEMENT, LLC 02/14/2025 636,300 $6.74 M   100.00% 0.40%
CALLAN CAPITAL, LLC 02/03/2025 636,194 $6.74 M   -3.78% 0.40%
CAPTION MANAGEMENT, LLC 02/14/2025 633,300 $6.71 M   100.00% 0.40%
MILLENNIUM MANAGEMENT LLC 02/14/2025 625,000 $6.63 M   100.00% 0.39%
LMR PARTNERS LLP 02/14/2025 616,400 $6.53 M   507.29% 0.39%
CANDRIAM S.C.A. 02/07/2025 571,027 $6.05 M   -15.56% 0.36%
SCHONFELD STRATEGIC ADVISORS LLC 02/14/2025 521,013 $5.52 M   273.92% 0.33%
AFFINITY ASSET ADVISORS, LLC 02/13/2025 475,000 $5.04 M   100.00% 0.30%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 437,800 $4.64 M   1,086.45% 0.27%
STEMPOINT CAPITAL LP 02/14/2025 428,137 $4.54 M   100.00% 0.27%
IKARIAN CAPITAL, LLC 02/14/2025 350,000 $3.71 M   -12.50% 0.22%
WOODLINE PARTNERS LP 02/14/2025 310,454 $3.29 M   0.94% 0.19%
CITADEL ADVISORS LLC 02/14/2025 295,400 $3.13 M   300.27% 0.19%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 289,300 $3.07 M   147.27% 0.18%
NOMURA HOLDINGS INC 02/14/2025 281,400 $2.98 M   100.00% 0.18%
SOROS CAPITAL MANAGEMENT LLC 02/14/2025 279,333 $2.96 M   -45.11% 0.18%
MILLENNIUM MANAGEMENT LLC 02/14/2025 257,430 $2.73 M   100.00% 0.16%
WEXFORD CAPITAL LP 02/14/2025 252,122 $2.67 M   15.72% 0.16%
CERITY PARTNERS LLC 02/13/2025 243,908 $2.59 M   0.42% 0.15%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 220,970 $2.34 M   -2.11% 0.14%
ALLIANCEBERNSTEIN L.P. 02/12/2025 199,947 $2.12 M   -10.29% 0.13%
BARCLAYS PLC 02/13/2025 166,822 $1.77 M   29.11% 0.10%
ADDIS & HILL, INC 01/31/2025 163,386 $1.73 M   -45.54% 0.10%

Neumora Therapeutics, Inc. Common Stock institutional Ownership - FAQ's

During the previous two years, 112 institutional investors and hedge funds held shares of Neumora Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:

Versant Capital Management, Inc: 0

Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 0

Ronald Blue Trust, Inc.: 0

GAMMA Investing LLC: 0

FMR LLC: 7.84 M

BlackRock, Inc.: 7.11 M

49.08% of Neumora Therapeutics, Inc. Common Stock stock is owned by institutional investors.

Institutional investors have bought a total of 79.00 M shares in the last 24 months. This purchase volume represents approximately $56.88 M in transactions.